Hi Susan,
Revlimid is an immunmodulating drug similar to Thalidomide but should not give neuropathy like Thalidomide can do.
Here is a study about Revlimid (Lenalidomide) in patients without isolated 5q- chromosome aberration. The results are best in patients with that chromosome aberration - about 70% respond.
In this study they didn’t give the patients Prednisone in tapering dose during the first 3 months - I don't know why because that is supposed to increase response.
As you can see 42% of the 31 low risk patients obtained a red blood cell response according to international criteria.
http://ash.confex.com/ash/2010/webpr...aper27957.html
Kind regards
Birgitta-A
71 yo, transfusion dependent since dx 2006 but no transfusions after 3 months treatment with Thalidomide Sept 2010.